摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-β-D-ribofuranosyl<1,2,4>triazole-3-carbonitrile | 123147-83-1

中文名称
——
中文别名
——
英文名称
1-β-D-ribofuranosyl<1,2,4>triazole-3-carbonitrile
英文别名
1-β-D-ribofuranozyl-1,2,4-triazole 3-carbonitrile;1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carbonitrile;1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-[1,2,4]triazole-3-carbonitrile;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carbonitrile
1-β-D-ribofuranosyl<1,2,4>triazole-3-carbonitrile化学式
CAS
123147-83-1
化学式
C8H10N4O4
mdl
——
分子量
226.192
InChiKey
JCLUSIUTVRQXRU-XVFCMESISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    577.9±60.0 °C(Predicted)
  • 密度:
    1.88±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.7
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    124
  • 氢给体数:
    3
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-β-D-ribofuranosyl<1,2,4>triazole-3-carbonitrile高氯酸 、 sodium hydride 、 溶剂黄146 作用下, 以 丙酮 为溶剂, 反应 9.67h, 生成 [(2R,3S,4R,5R)-5-(3-氰基-1,2,4-三唑-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基磺酸
    参考文献:
    名称:
    Synthesis, structure, and antiparasitic activity of sulfamoyl derivatives of ribavirin
    摘要:
    The triazole nucleoside derivatives 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl) [1,2,4]triazole-3-carboxamide (2), 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl) [1,2,4]triazole-3-thiocarboxamide (3), and 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl)-[1,2,4]triazole-3- carbonitrile (4) were synthesized. Suitably protected triazole nucleosides were converted to their corresponding 5'-sulfamoyl derivatives, which on subsequent deprotection gave the desired compounds in good yields. The structures of compounds 2-4 were confirmed by X-ray crystallographic analysis. All three compounds showed significant antiparasitic activity in vitro, while 2 showed significant activity in vivo against Leishmania donovani and Trypanosoma brucei.
    DOI:
    10.1021/jm00163a008
  • 作为产物:
    描述:
    3-氰基-1-(2,3,5-三-O-乙酰基-beta-D-呋喃核糖基)-1,2,4-三唑盐酸 作用下, 反应 24.0h, 以91%的产率得到1-β-D-ribofuranosyl<1,2,4>triazole-3-carbonitrile
    参考文献:
    名称:
    Synthesis, structure, and antiparasitic activity of sulfamoyl derivatives of ribavirin
    摘要:
    The triazole nucleoside derivatives 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl) [1,2,4]triazole-3-carboxamide (2), 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl) [1,2,4]triazole-3-thiocarboxamide (3), and 1-(5'-O-sulfamoyl-beta-D-ribofuranosyl)-[1,2,4]triazole-3- carbonitrile (4) were synthesized. Suitably protected triazole nucleosides were converted to their corresponding 5'-sulfamoyl derivatives, which on subsequent deprotection gave the desired compounds in good yields. The structures of compounds 2-4 were confirmed by X-ray crystallographic analysis. All three compounds showed significant antiparasitic activity in vitro, while 2 showed significant activity in vivo against Leishmania donovani and Trypanosoma brucei.
    DOI:
    10.1021/jm00163a008
点击查看最新优质反应信息

文献信息

  • Chemoenzymatic method of 1,2,4-triazole nucleoside synthesis: Possibilities and limitations
    作者:I. D. Konstantinova、M. V. Chudinov、I. V. Fateev、A. V. Matveev、N. I. Zhurilo、V. I. Shvets、A. I. Miroshnikov
    DOI:10.1134/s1068162013010056
    日期:2013.1
    of novel structural analogues of an antiviral preparation of Ribavirin (1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide) were established. A synthesis of various amides of 1H-1,2,4-triazole-3-carboxylic acid and its 5-substituted analogues—potential substrates of purine nucleoside phosphorylase—has been described. Comparative efficiency of preparation methods of these amides, as well as the methods
    确定了利巴韦林(1-β-D-呋喃核糖基-1,2,4-三唑-3-甲酰胺)抗病毒制剂的新型结构类似物的化学酶促合成的可能性和局限性。已经描述了 1H-1,2,4-三唑-3-羧酸及其 5-取代类似物(嘌呤核苷磷酸化酶的潜在底物)的各种酰胺的合成。研究了这些酰胺的制备方法的比较效率,以及将官能团引入杂环系统的C5位置的方法。合成了在羧酰胺组中含有各种取代基的新型病毒唑类似物。开发了一种生物技术方法来制备 1-β-D-呋喃核糖基-1,2,4-三唑-3-羰基,这是一种合成病毒脒(病毒唑的现代类似物)的中间体。
  • ANTIVIRAL PHOSPHONATE ANALOGS
    申请人:Boojamra Constantine G.
    公开号:US20090275535A1
    公开(公告)日:2009-11-05
    The invention is related to phosphorus substituted compounds with antiviral activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    这项发明涉及具有抗病毒活性的磷取代化合物,包含这种化合物的组合物以及包括给予这种化合物的治疗方法,还包括用于制备这种化合物的过程和中间体。
  • KINI, GANESH D.;HENRY, ELIZABETH M.;ROBINS, ROLAND K.;LARSON, STEVEN B.;M+, J. MED. CHEM., 33,(1990) N, C. 44-48
    作者:KINI, GANESH D.、HENRY, ELIZABETH M.、ROBINS, ROLAND K.、LARSON, STEVEN B.、M+
    DOI:——
    日期:——
  • Nucleoside Phosphonate Analogs
    申请人:Boojamra Constantine G.
    公开号:US20110071101A1
    公开(公告)日:2011-03-24
    The invention is related to phosphorus substituted nucleoside compounds and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
  • US3991078A
    申请人:——
    公开号:US3991078A
    公开(公告)日:1976-11-09
查看更多

同类化合物

利巴韦林杂质G 利巴韦林杂质E 利巴韦林杂质B 利巴韦林 利巴韦林 三氮唑核苷脒盐酸盐 三氮唑核苷羧酸 三氮唑核苷5'-氨基磺酸 三氮唑核苷-5'-磷酸酯 三氮唑核苷 5'-二磷酸酯 三氮唑核苷 5'-三磷酸酯 三氮唑核苷 2',3',5'-三乙酸酯 三乙酰利巴韦林甲酯 [5-(3-氨基-1,2,4-三唑-1-基)-3,4-二苯甲酰氧基-四氢呋喃-2-基]甲基苯甲酸酯 [(2R,3S,4R,5R)-5-(3-硫代氨基甲酰-1,2,4-三唑-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基磺酸 [(2R,3S,4R,5R)-5-(3-氨基羰基-1,2,4-三唑-1-基)-3,4-二羟基-四氢呋喃-2-基]甲基二氢磷酸酯与N,N-二乙基乙胺的化合物 5-氨基-1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲脒盐酸盐 5'-O-吡喃葡萄糖基三氮唑核苷 5'-O-吡喃半乳糖基三氮唑核苷 3-氰基-1-(2,3,5-三-O-乙酰基-beta-D-呋喃核糖基)-1,2,4-三唑 2’,3’-异亚丙基三氮唑核苷 2',3'-异亚丙基α-利巴韦林 2'-脱氧三氮唑核苷 1-Β-D-呋喃核糖基-1H-1,2,4-三氮唑-3-羧酸甲酯 1-[2,3-O-异亚丙基-beta-D-呋喃核糖基]-1,2,4-三唑-3-羧酸甲酯 1-[(2S,3S,4S,5S)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-[(2R,3R,4R,5R)-3,4-二丁氧基-5-(丁氧基甲基)四氢呋喃-2-基]-1,2,4-三唑-3-甲酰胺 1-(2-C-甲基-BETA-D-呋喃核糖基)-1H-1,2,4-三唑-3-甲酰胺 (2R,3S,4R,5R)-2-(羟基甲基)-5-[3-(甲氧基亚胺甲酰基)-1,2,4-三唑-1-基]四氢呋喃-3,4-二醇 (2R,3R,4S,5R)-2-[3-(乙氧基亚胺甲酰基)-1,2,4-三唑-1-基]-5-(羟基甲基)四氢呋喃-3,4-二醇 N1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-C4-(coumarin-7-oxymethyl)-1,2,3-triazole 4,5-dibromo-1-(5-O-sulfamoyl-β-D-ribofuranosyl)triazole (2R,3R,4S,5R)-3'-(2-fluorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 4-((1-(β-D-ribofuranos-1-yl)-1,2,3-triazol-4-yl)methoxy)-2-phenylquinazoline ribavirin-5’-O-bis(benzoxy-L-alaninyl)phoshate 1-(5-deoxy-5-N-phosphonomethylamino-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (2R,3R,4S,5R)-3'-(4-chlorophenyl)-5-(hydroxymethyl)-4,5-dihydro-3H,4'H,6'H-spiro[furan-2,7'-[1,2,3]triazolo[5,1-c][1,4]oxazine]-3,4-diol 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)-4-cyclopropyl-[1,2,3]-triazole 1-(5-O-thiophosphoryl-β-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide 5-[2-(4-chlorophenyl)ethynyl]-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(1-methylimidazol-4-yl)ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-[2-(trifluoromethyl)phenyl]ethynyl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(4-methylphenyl)ethynyl]-1,2,4-triazole-3-carboxamide 5-(4-trifluoromethylphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(2-phenylethynyl)-1,2,4-triazole-3-carboxamide 5-(5-chloropent-1-ynyl)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 5-(3-trifluoromethyl-phenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(thiophen-3-ylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 5-(4-methoxyphenylethynyl)-1-(2,3,5-tri-hydroxy-β-D-ribofuranosyl)-1H-[1,2,4]triazole-3-carboxylic acid amide 4-tetradecyloxymethyl-1-(β-D-arabinofuranosyl)-1,2,3-triazole